Resolvin D1 Inhibits Corneal Inflammation in Staphylococcus Aureus Keratitis

References

• Buckley CD, Gilroy DW, Serhan CN. Proresolving lipid mediators and mechanisms in the resolution of acute inflammation. Immunity. 2014 Mar 20;40(3):315–327. doi:10.1016/j.immuni.2014.02.009.
   PubMed Web of Science ®Google Scholar
• Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014 Jun 5;510(7503):92–101. doi:10.1038/nature13479.
   PubMed Web of Science ®Google Scholar
• Wang J. Neutrophils in tissue injury and repair. Cell Tissue Res. 2018 Mar;371(3):531–539. doi:10.1007/s00441-017-2785-7. Epub 2018 Jan 30.
   PubMed Web of Science ®Google Scholar
• Castanheira FVS, Kubes P. Neutrophils and NETs in modulating acute and chronic inflammation. Blood. 2019 May 16;133(20):2178–2185. doi:10.1182/blood-2018-11-844530. Epub 2019 Mar 21.
   PubMed Web of Science ®Google Scholar
• Dalli J, Serhan CN. Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators. Blood. 2012 Oct 11;120(15):e60–72. doi:10.1182/blood-2012-04-423525. Epub 2012 Aug 17.
   PubMed Web of Science ®Google Scholar
• Kang JW, Lee SM. Resolvin D1 protects the liver from ischemia/reperfusion injury by enhancing M2 macrophage polarization and efferocytosis. Biochim Biophys Acta. 2016 Sep;1861(9 Pt A):1025–1035. doi:10.1016/j.bbalip.2016.06.002. Epub 2016 Jun 15.
   PubMed Web of Science ®Google Scholar
• Duffield JS, Hong S, Vaidya VS, et al. Resolvin D series and protectin D1 mitigate acute kidney injury. J Immunol. 2006 Nov 1;177(9):5902–5911. doi:10.4049/jimmunol.177.9.5902.
   PubMed Web of Science ®Google Scholar
• Xu MX, Tan BC, Zhou W, et al. Resolvin D1, an endogenous lipid mediator for inactivation of inflammation-related signalling pathways in microglial cells, prevents lipopolysaccharide-induced inflammatory responses. CNS Neurosci Ther. 2013 Apr;19(4):235–243. doi:10.1111/cns.12069.
   PubMed Web of Science ®Google Scholar
• Liao Z, Dong J, Wu W, et al. Resolvin D1 attenuates inflammation in lipopolysaccharide-induced acute lung injury through a process involving the PPARγ/NF-κB pathway. Respir Res. 2012 Dec 2;13(1):110. doi:10.1186/1465-9921-13-110.
   PubMedGoogle Scholar
• Yin Y, Chen F, Wang W, Wang H, Zhang X. Resolvin D1 inhibits inflammatory response in STZ-induced diabetic retinopathy rats: possible involvement of NLRP3 inflammasome and NF-κB signaling pathway. Mol Vis. 2017 Apr 14;23:242–250.
   PubMed Web of Science ®Google Scholar
• Johnson AC, Heinzel FP, Diaconu E, et al. Activation of toll-like receptor (TLR)2, TLR4, and TLR9 in the mammalian cornea induces MyD88-dependent corneal inflammation. Invest Ophthalmol Vis Sci. 2005 Feb;46(2):589–595. doi:10.1167/iovs.04-1077.
   PubMed Web of Science ®Google Scholar
• Lee JE, Sun Y, Gjorstrup P, Pearlman E. Inhibition of corneal inflammation by the resolvin E1 [published correction appears in Invest Ophthalmol Vis Sci. 2015 Sep;56(10):5739]. Invest Ophthalmol Vis Sci. 2015;56(4):2728–2736. doi:10.1167/iovs.14-15982.
   PubMed Web of Science ®Google Scholar
• Roy S, Sun Y, Pearlman E. Interferon-gamma-induced MD-2 protein expression and lipopolysaccharide (LPS) responsiveness in corneal epithelial cells is mediated by Janus tyrosine kinase-2 activation and direct binding of STAT1 protein to the MD-2 promoter. J Biol Chem. 2011 Jul 8;286(27):23753–23762. doi:10.1074/jbc.M111.219345. Epub 2011 May 13.
   PubMed Web of Science ®Google Scholar
• Pearlman E, Sun Y, Roy S, et al. Host defense at the ocular surface. Int Rev Immunol. 2013 Feb;32(1):4–18. doi:10.3109/08830185.2012.749400.
   PubMed Web of Science ®Google Scholar
• Spandau UH, Toksoy A, Verhaart S, Gillitzer R, Kruse FE. High expression of chemokines Gro-alpha (CXCL-1), IL-8 (CXCL-8), and MCP-1 (CCL-2) in inflamed human corneas in vivo. Arch Ophthalmol. 2003 Jun;121(6):825–831. doi:10.1001/archopht.121.6.825.
   PubMedGoogle Scholar
• Leech JM, Lacey KA, Mulcahy ME, Medina E, McLoughlin RM. IL-10 plays opposing roles during Staphylococcus aureus systemic and localized infections. J Immunol. 2017 Mar 15;198(6):2352–2365. doi:10.4049/jimmunol.1601018. Epub 2017 Feb 6.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Hu X, Qi X, et al. Resolvin D1 promotes corneal epithelial wound healing and restoration of mechanical sensation in diabetic mice. Mol Vis. 2018 Apr 1;24:274–285.
   PubMed Web of Science ®Google Scholar
• Rajasagi NK, Bhela S, Varanasi SK, Rouse BT. Frontline science: aspirin-triggered resolvin D1 controls herpes simplex virus-induced corneal immunopathology. J Leukoc Biol. 2017 Nov;102(5):1159–1171. doi:10.1189/jlb.3HI1216-511RR. Epub 2017 Jun 5.
   PubMed Web of Science ®Google Scholar
• Petrillo F, Trotta MC, Bucolo C, et al. Resolvin D1 attenuates the inflammatory process in mouse model of LPS-induced keratitis. J Cell Mol Med. 2020 Nov;24(21):12298–12307. doi:10.1111/jcmm.15633. Epub 2020 Oct 15.
   PubMed Web of Science ®Google Scholar
• Erdinest N, Ovadia H, Kormas R, Solomon A. Anti-inflammatory effects of resolvin-D1 on human corneal epithelial cells: in vitro study. J Inflamm (Lond). 2014 Mar 2;11(1):6. doi:10.1186/1476-9255-11-6.
   PubMedGoogle Scholar
• Settimio R, Clara DF, Franca F, Francesca S, Michele D. Resolvin D1 reduces the immunoinflammatory response of the rat eye following uveitis. Mediators Inflamm. 2012;2012:318621. doi:10.1155/2012/318621. Epub 2012 Dec 10.
   PubMed Web of Science ®Google Scholar
• Liu T, Zhang L, Joo D, et al. NF-κB signaling in inflammation. Sig Transduct Target Ther. 2017;2:17023. doi:10.1038/sigtrans.2017.23.
   PubMed Web of Science ®Google Scholar
• Sun Y, Hise AG, Kalsow CM, Pearlman E. Staphylococcus aureus-induced corneal inflammation is dependent on Toll-like receptor 2 and myeloid differentiation factor 88. Infect Immun. 2006 Sep;74(9):5325–5332. doi:10.1128/IAI.00645-06.
   PubMed Web of Science ®Google Scholar
• Kumar A, Yu FS. Toll-like receptors and corneal innate immunity. Curr Mol Med. 2006 May;6(3):327–337. doi:10.2174/156652406776894572.
   PubMed Web of Science ®Google Scholar
• Hos D, Bucher F, Regenfuss B, et al. IL-10 indirectly regulates corneal lymphangiogenesis and resolution of inflammation via macrophages. Am J Pathol. 2016 Jan;186(1):159–171. doi:10.1016/j.ajpath.2015.09.012. Epub 2015 Nov 20.
   PubMed Web of Science ®Google Scholar
• Keadle TL, Stuart PM. Interleukin-10 (IL-10) ameliorates corneal disease in a mouse model of recurrent herpetic keratitis. Microb Pathog. 2005 Jan;38(1):13–21. doi:10.1016/j.micpath.2004.09.003. Epub 2004 Dec 8.
   PubMed Web of Science ®Google Scholar
• Cole N, Krockenberger M, Stapleton F, et al. Experimental Pseudomonas aeruginosa keratitis in interleukin-10 gene knockout mice. Infect Immun. 2003 Mar;71(3):1328–1336. doi:10.1128/IAI.71.3.1328-1336.2003.
   PubMed Web of Science ®Google Scholar
• Jin L, Batra S, Douda DN, Palaniyar N, Jeyaseelan S. CXCL1 contributes to host defense in polymicrobial sepsis via modulating T cell and neutrophil functions. J Immunol. 2014 Oct 1;193(7):3549–3558. doi:10.4049/jimmunol.1401138. Epub 2014 Aug 29.
   PubMed Web of Science ®Google Scholar
• Cho YW, Yoo WS, Kim SJ, Chung IY, Seo SW, Yoo JM. Efficacy of systemic vitamin C supplementation in reducing corneal opacity resulting from infectious keratitis. Medicine (Baltimore). 2014 Nov;93(23):e125. doi:10.1097/MD.0000000000000125.
   PubMed Web of Science ®Google Scholar
• Carion TW, Kracht D, Strand E, et al. VIP modulates the ALX/FPR2 receptor axis toward inflammation resolution in a mouse model of bacterial keratitis. Prostaglandins Other Lipid Mediat. 2019 Feb;140:18–25. doi:10.1016/j.prostaglandins.2018.12.001. Epub 2018 Dec 4.
   PubMed Web of Science ®Google Scholar